Issue 17 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Miami's Sylvester uses cool art to bridge disparities—and meet NCI's new requirement

Peter Tunney: How the largest art movement in history can help reduce cancer disparities

Learning to “talk less and smile more” while designing a COE strategy worthy of trust

In Brief

John Sampson to lead Duke's physician practice of over 1,500 members

Carl Schmidt joins WVU Cancer Institute

NCCN publishes translations of guidelines for patients

Melanoma Research Alliance announces $11.8 Million in 28 research grants

2018 Awards

Young Investigator Awards

Clinical Roundup

TESARO announces positive top-line results from Quadra trial of Zejula

Drugs & Targets

Mylotarg approved in EU for previously untreated, de novo, CD33-positive AML in combination with Chemotherapy

Nektar, Takeda to evaluate combining CD122-biased agonist and dual SYK and FLT-3 inhibitor

Pfizer gets Complete Response Letter for trastuzumab biosimilar

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login